Quarterly Consolidated Statement Of Cash Flows

CellSeed Inc. - Filing #7272610

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-857,550,000 JPY
-845,584,000 JPY
Depreciation
JPY
7,939,000 JPY
Impairment losses
18,367,000 JPY
112,028,000 JPY
Interest expenses
2,057,000 JPY
1,128,000 JPY
Decrease (increase) in trade receivables
14,745,000 JPY
-26,095,000 JPY
Decrease (increase) in inventories
201,000 JPY
9,974,000 JPY
Increase (decrease) in trade payables
2,404,000 JPY
3,384,000 JPY
Subtotal
-863,276,000 JPY
-777,465,000 JPY
Interest paid
-2,076,000 JPY
-1,032,000 JPY
Income taxes paid
-947,000 JPY
-948,000 JPY
Net cash provided by (used in) operating activities
-866,104,000 JPY
-779,435,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-18,367,000 JPY
-21,632,000 JPY
Net cash provided by (used in) investing activities
-18,367,000 JPY
56,315,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-7,500,000 JPY
-7,500,000 JPY
Net cash provided by (used in) financing activities
855,479,000 JPY
1,814,201,000 JPY
Net increase (decrease) in cash and cash equivalents
-28,992,000 JPY
1,091,081,000 JPY
Cash and cash equivalents
2,134,299,000 JPY
2,163,292,000 JPY
1,072,210,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.